BALAXI PHARMACEUTICALS
Back to Income Statement
|
BALAXI PHARMACEUTICALS Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹45 Cr | ₹57 Cr | ₹51 Cr | ₹43 Cr | ₹8.25 Cr |
What is the latest Operating Profit of BALAXI PHARMACEUTICALS ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹45 Cr |
| Mar2024 | ₹57 Cr |
| Mar2023 | ₹51 Cr |
| Mar2022 | ₹43 Cr |
| Mar2021 | ₹8.25 Cr |
How is Operating Profit of BALAXI PHARMACEUTICALS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹45 Cr | -22.42 | |
| Mar2024 | ₹57 Cr | 12.97 | |
| Mar2023 | ₹51 Cr | 19.08 | |
| Mar2022 | ₹43 Cr | 417.06 | |
| Mar2021 | ₹8.25 Cr | - | |
Compare Operating Profit of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹104.2 Cr | -5.7% | -22.7% | -65.1% | Stock Analytics | |
| ADANI ENTERPRISES | ₹274,469.0 Cr | -2.7% | 9.3% | 5.6% | Stock Analytics | |
| REDINGTON | ₹20,545.0 Cr | 9.5% | -1.4% | 12% | Stock Analytics | |
| HONASA CONSUMER | ₹9,530.1 Cr | -4.2% | 5.6% | 35.7% | Stock Analytics | |
| MMTC | ₹8,791.5 Cr | -4.9% | -7.1% | 12.7% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹7,576.3 Cr | -8.1% | -11.4% | 18% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -5.7% |
-22.7% |
-65.1% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses